Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Infectious Diseases of Poverty
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-04-24
DOI
10.1186/s40249-023-01086-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Post-COVID-19 arthritis: is it hyperinflammation or autoimmunity?
- (2022) Sara Ibrahim Taha et al. EUROPEAN CYTOKINE NETWORK
- Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome
- (2022) Yeny Acosta-Ampudia et al. JOURNAL OF INFECTIOUS DISEASES
- Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients
- (2022) Sven Jarius et al. Journal of Neuroinflammation
- The Female-Predominant Persistent Immune Dysregulation of the Post-COVID Syndrome
- (2022) Ravindra Ganesh et al. MAYO CLINIC PROCEEDINGS
- Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome
- (2022) Carlo Cervia et al. Nature Communications
- Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial
- (2022) Camila Miriam Suemi Sato Barros et al. Frontiers in Medicine
- Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case–Control Study
- (2022) Maria Albanese et al. Pharmaceuticals
- Increasing awareness of HIV pre‐exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta‐analysis of global data
- (2022) Zhishan Sun et al. Journal of the International AIDS Society
- SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2
- (2022) Katherine M. Littlefield et al. PLoS Pathogens
- Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial
- (2022) Irina Karosanidze et al. Pharmaceuticals
- Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome
- (2022) Maria Alice Freitas Queiroz et al. Frontiers in Cellular and Infection Microbiology
- Assessment of performance for a key indicator of One Health: evidence based on One Health index for zoonoses in Sub-Saharan Africa
- (2022) Han-Qing Zhao et al. Infectious Diseases of Poverty
- Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment
- (2021) Jian Wu et al. Frontiers in Immunology
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health
- (2021) Liam Townsend et al. Frontiers in Immunology
- Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)
- (2021) Edina Cenko et al. CARDIOVASCULAR RESEARCH
- Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19
- (2021) Nils Kappelmann et al. PSYCHONEUROENDOCRINOLOGY
- Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
- (2021) Amy D. Proal et al. Frontiers in Microbiology
- Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning
- (2021) Bruce K. Patterson et al. Frontiers in Immunology
- Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged ≥18 Years — Long Beach, California, April 1–December 10, 2020
- (2021) Kyle Yomogida et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection
- (2021) Marc Scherlinger et al. Infectious Diseases and Therapy
- Mast cell activation is associated with post‐acute COVID‐19 syndrome
- (2021) Joshua B. Wechsler et al. ALLERGY
- Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study
- (2021) Kadalraja Raghavan et al. BIOMEDICINE & PHARMACOTHERAPY
- Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- (2021) Michael J Peluso et al. JOURNAL OF INFECTIOUS DISEASES
- Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-β but Higher Levels of IL-1α and TGF-β
- (2021) Chiara Colarusso et al. Biomedicines
- Sensitivity analysis methods in the biomedical sciences
- (2020) George Qian et al. MATHEMATICAL BIOSCIENCES
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Association of inflammatory markers with the severity of COVID-19: a meta-analysis
- (2020) Furong Zeng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins
- (2020) Tommy Tsan-Yuk Lam et al. NATURE
- Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
- (2020) Yonggang Zhou et al. National Science Review
- LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis
- (2020) Yannick Luther Agbana et al. BMC CANCER
- Persistent Symptoms in Patients After Acute COVID-19
- (2020) Angelo Carfì et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Post‐discharge symptoms and rehabilitation needs in survivors of COVID‐19 infection: a cross‐sectional evaluation
- (2020) Stephen J Halpin et al. JOURNAL OF MEDICAL VIROLOGY
- Covid-19: What do we know about “long covid”?
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis
- (2020) Eric A. Coomes et al. REVIEWS IN MEDICAL VIROLOGY
- A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection
- (2020) S. Deblina Datta et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Defining IL‐6 levels in healthy individuals: A meta‐analysis
- (2020) Elias A. Said et al. JOURNAL OF MEDICAL VIROLOGY
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Dynamics of a Cytokine Storm
- (2012) Hao Hong Yiu et al. PLoS One
- Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods
- (2011) Jan O. Friedrich et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Release of Inflammatory Mediators by Human Adipose Tissue Is Enhanced in Obesity and Primarily by the Nonfat Cells: A Review
- (2010) John N. Fain MEDIATORS OF INFLAMMATION
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: A simulation study
- (2008) Jan O Friedrich et al. BMC Medical Research Methodology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started